Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Graves Disease | 19 | 2016 | 241 | 1.710 |
Why?
|
Graves Ophthalmopathy | 3 | 2022 | 117 | 1.020 |
Why?
|
Thyroglobulin | 6 | 2021 | 114 | 0.990 |
Why?
|
Thyroid Gland | 14 | 2018 | 1169 | 0.930 |
Why?
|
Thyroiditis, Autoimmune | 11 | 2003 | 101 | 0.800 |
Why?
|
Thyroiditis | 2 | 2020 | 84 | 0.770 |
Why?
|
Receptors, Thyrotropin | 4 | 2022 | 45 | 0.690 |
Why?
|
Thyrotropin | 7 | 2016 | 849 | 0.630 |
Why?
|
Thyroid Neoplasms | 8 | 2021 | 2267 | 0.610 |
Why?
|
Thyroid Nodule | 5 | 2018 | 750 | 0.550 |
Why?
|
Hyperthyroidism | 5 | 2016 | 293 | 0.520 |
Why?
|
Biotin | 1 | 2016 | 253 | 0.520 |
Why?
|
Triiodothyronine | 3 | 2016 | 491 | 0.500 |
Why?
|
Thyroid Hormones | 3 | 2018 | 387 | 0.480 |
Why?
|
Thyroxine | 6 | 2016 | 666 | 0.460 |
Why?
|
Thyroid Diseases | 9 | 2018 | 378 | 0.440 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2012 | 60 | 0.400 |
Why?
|
Iodine Radioisotopes | 6 | 2012 | 1031 | 0.400 |
Why?
|
Lod Score | 9 | 2007 | 615 | 0.390 |
Why?
|
Autoimmune Diseases of the Nervous System | 1 | 2011 | 67 | 0.380 |
Why?
|
Autoantibodies | 11 | 2013 | 2020 | 0.380 |
Why?
|
Pituitary Diseases | 1 | 2011 | 141 | 0.370 |
Why?
|
Thyroidectomy | 4 | 2012 | 876 | 0.320 |
Why?
|
Hypothyroidism | 4 | 2011 | 659 | 0.300 |
Why?
|
Immunoconjugates | 4 | 2001 | 889 | 0.260 |
Why?
|
Autoimmunity | 2 | 2011 | 1344 | 0.250 |
Why?
|
Thyroid Function Tests | 2 | 2018 | 284 | 0.250 |
Why?
|
Exophthalmos | 2 | 2022 | 95 | 0.210 |
Why?
|
Aging | 5 | 2018 | 8613 | 0.200 |
Why?
|
Antigens, Differentiation | 5 | 2003 | 925 | 0.190 |
Why?
|
Antibodies, Heterophile | 1 | 2021 | 128 | 0.190 |
Why?
|
Glucocorticoids | 3 | 2022 | 2100 | 0.140 |
Why?
|
X Chromosome | 2 | 1999 | 815 | 0.130 |
Why?
|
Adenocarcinoma, Follicular | 3 | 2012 | 320 | 0.130 |
Why?
|
Tissue and Organ Harvesting | 1 | 2017 | 353 | 0.120 |
Why?
|
Chromosomes, Human, Pair 14 | 4 | 1999 | 300 | 0.120 |
Why?
|
Living Donors | 1 | 2017 | 617 | 0.110 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 15070 | 0.110 |
Why?
|
Immunity | 1 | 1998 | 1008 | 0.100 |
Why?
|
Ethanol | 1 | 2018 | 1329 | 0.100 |
Why?
|
Chromosomes, Human, Pair 2 | 3 | 2003 | 326 | 0.100 |
Why?
|
Methylprednisolone | 3 | 2022 | 388 | 0.100 |
Why?
|
Humans | 52 | 2022 | 739398 | 0.100 |
Why?
|
Ultrasonography | 3 | 2020 | 5941 | 0.100 |
Why?
|
Cross-Cultural Comparison | 1 | 2014 | 648 | 0.100 |
Why?
|
Maternal-Fetal Exchange | 1 | 2013 | 454 | 0.100 |
Why?
|
Anti-Retroviral Agents | 1 | 2020 | 1734 | 0.090 |
Why?
|
Paraganglioma | 1 | 2011 | 144 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 8 | 2007 | 17384 | 0.090 |
Why?
|
Quality of Life | 3 | 2022 | 12640 | 0.090 |
Why?
|
Microsatellite Repeats | 6 | 2003 | 797 | 0.090 |
Why?
|
Chromosome Mapping | 7 | 2007 | 4743 | 0.080 |
Why?
|
Sex Characteristics | 2 | 1999 | 2583 | 0.080 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1253 | 0.080 |
Why?
|
Amiodarone | 1 | 2010 | 211 | 0.080 |
Why?
|
Autoimmune Diseases | 6 | 1999 | 2116 | 0.080 |
Why?
|
Receptors, Interleukin-2 | 3 | 1994 | 572 | 0.070 |
Why?
|
Lithium | 1 | 2010 | 603 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12948 | 0.070 |
Why?
|
Carcinoma, Papillary | 2 | 2007 | 779 | 0.070 |
Why?
|
Hashimoto Disease | 1 | 2007 | 90 | 0.070 |
Why?
|
Myasthenia Gravis | 2 | 2000 | 201 | 0.070 |
Why?
|
Immunomodulation | 1 | 2010 | 540 | 0.070 |
Why?
|
Antibodies, Monoclonal | 3 | 2022 | 9259 | 0.070 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2010 | 788 | 0.070 |
Why?
|
Genetic Linkage | 3 | 2001 | 2433 | 0.070 |
Why?
|
Genetic Heterogeneity | 2 | 2007 | 727 | 0.070 |
Why?
|
Drug Interactions | 1 | 2010 | 1456 | 0.070 |
Why?
|
Patient Selection | 1 | 2017 | 4211 | 0.060 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2007 | 224 | 0.060 |
Why?
|
Hormone Replacement Therapy | 1 | 2010 | 740 | 0.060 |
Why?
|
Drug Monitoring | 1 | 2010 | 961 | 0.060 |
Why?
|
Diplopia | 2 | 2022 | 194 | 0.060 |
Why?
|
Antigens, CD | 5 | 2003 | 4024 | 0.060 |
Why?
|
Dietary Supplements | 1 | 2016 | 3279 | 0.060 |
Why?
|
Self Report | 1 | 2014 | 3524 | 0.060 |
Why?
|
Middle Aged | 22 | 2016 | 212863 | 0.050 |
Why?
|
Practice Guidelines as Topic | 2 | 2017 | 7274 | 0.050 |
Why?
|
Female | 36 | 2014 | 378853 | 0.050 |
Why?
|
Chromosomes, Human, Pair 20 | 2 | 1999 | 133 | 0.050 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2003 | 905 | 0.050 |
Why?
|
Disease-Free Survival | 1 | 2012 | 6871 | 0.050 |
Why?
|
Polyendocrinopathies, Autoimmune | 1 | 2001 | 55 | 0.050 |
Why?
|
Survival Analysis | 2 | 2012 | 10247 | 0.050 |
Why?
|
Aged | 19 | 2018 | 162698 | 0.050 |
Why?
|
Male | 32 | 2016 | 349022 | 0.050 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2010 | 2455 | 0.050 |
Why?
|
vpr Gene Products, Human Immunodeficiency Virus | 1 | 2020 | 39 | 0.050 |
Why?
|
Immunogenetics | 1 | 2000 | 67 | 0.050 |
Why?
|
Genes, Regulator | 1 | 2001 | 378 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2018 | 62693 | 0.050 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 1 | 2020 | 126 | 0.050 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 1 | 2020 | 151 | 0.050 |
Why?
|
Forkhead Transcription Factors | 1 | 2007 | 1602 | 0.040 |
Why?
|
Iodide Peroxidase | 3 | 1999 | 293 | 0.040 |
Why?
|
Sialoglycoproteins | 1 | 2000 | 318 | 0.040 |
Why?
|
Goiter, Nodular | 1 | 1998 | 24 | 0.040 |
Why?
|
Aromatase | 1 | 1998 | 146 | 0.040 |
Why?
|
Biopsy, Fine-Needle | 2 | 2012 | 1089 | 0.040 |
Why?
|
Italy | 2 | 2014 | 827 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 1998 | 374 | 0.040 |
Why?
|
Antipsychotic Agents | 1 | 2010 | 3055 | 0.040 |
Why?
|
Prognosis | 2 | 2017 | 28901 | 0.040 |
Why?
|
Genetic Testing | 2 | 2007 | 3441 | 0.040 |
Why?
|
Symporters | 1 | 1999 | 364 | 0.030 |
Why?
|
Adult | 21 | 2014 | 213394 | 0.030 |
Why?
|
Serbia | 1 | 2014 | 15 | 0.030 |
Why?
|
Genetic Markers | 2 | 1998 | 2630 | 0.030 |
Why?
|
Translations | 1 | 2014 | 64 | 0.030 |
Why?
|
HLA Antigens | 1 | 2000 | 1382 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 1998 | 805 | 0.030 |
Why?
|
Methimazole | 3 | 2000 | 41 | 0.030 |
Why?
|
Microsomes | 1 | 1994 | 257 | 0.030 |
Why?
|
Genome, Human | 2 | 2007 | 4419 | 0.030 |
Why?
|
Environment | 1 | 2000 | 1110 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 5502 | 0.030 |
Why?
|
HIV Infections | 1 | 2020 | 16764 | 0.030 |
Why?
|
Pregnancy | 3 | 2013 | 29002 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2012 | 38942 | 0.030 |
Why?
|
Denmark | 1 | 2014 | 730 | 0.030 |
Why?
|
Sweden | 1 | 2014 | 1336 | 0.020 |
Why?
|
Risk Factors | 1 | 2018 | 71974 | 0.020 |
Why?
|
Mass Screening | 1 | 2007 | 5265 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2012 | 76631 | 0.020 |
Why?
|
Carcinoma, Medullary | 1 | 2011 | 122 | 0.020 |
Why?
|
United States | 1 | 2018 | 69573 | 0.020 |
Why?
|
Antithyroid Agents | 2 | 2000 | 68 | 0.020 |
Why?
|
Culture | 1 | 2014 | 627 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 1998 | 2183 | 0.020 |
Why?
|
Personal Satisfaction | 1 | 2014 | 629 | 0.020 |
Why?
|
Netherlands | 1 | 2014 | 2169 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 1999 | 2517 | 0.020 |
Why?
|
Disease Management | 1 | 2020 | 2448 | 0.020 |
Why?
|
Genotype | 2 | 2003 | 12951 | 0.020 |
Why?
|
Liver Function Tests | 1 | 1989 | 527 | 0.020 |
Why?
|
Watchful Waiting | 1 | 2012 | 489 | 0.020 |
Why?
|
India | 1 | 2014 | 2189 | 0.020 |
Why?
|
Bile Acids and Salts | 1 | 1989 | 354 | 0.020 |
Why?
|
Laryngeal Neoplasms | 1 | 2011 | 509 | 0.020 |
Why?
|
Peroxidase | 1 | 1990 | 608 | 0.020 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2011 | 324 | 0.020 |
Why?
|
Smoking | 2 | 2001 | 8960 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3510 | 0.020 |
Why?
|
Language | 1 | 2014 | 1447 | 0.020 |
Why?
|
North America | 2 | 1998 | 1249 | 0.020 |
Why?
|
Radiotherapy | 1 | 2012 | 1526 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 1998 | 4143 | 0.020 |
Why?
|
Animals | 3 | 2010 | 168368 | 0.020 |
Why?
|
Ultrasonography, Doppler | 1 | 2007 | 460 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 1999 | 3497 | 0.020 |
Why?
|
Intraoperative Complications | 1 | 2011 | 1184 | 0.010 |
Why?
|
Hemagglutination Tests | 2 | 1994 | 75 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 2003 | 6174 | 0.010 |
Why?
|
Reference Values | 2 | 2003 | 4983 | 0.010 |
Why?
|
Europe | 2 | 1998 | 3331 | 0.010 |
Why?
|
Radioimmunoassay | 2 | 1994 | 918 | 0.010 |
Why?
|
Transcription Factors | 1 | 2001 | 12120 | 0.010 |
Why?
|
Risk Assessment | 2 | 2017 | 23294 | 0.010 |
Why?
|
Sex Distribution | 1 | 2007 | 2296 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2007 | 1637 | 0.010 |
Why?
|
Alleles | 2 | 2003 | 6942 | 0.010 |
Why?
|
Age Distribution | 1 | 2007 | 2904 | 0.010 |
Why?
|
Genes, Recessive | 1 | 2003 | 650 | 0.010 |
Why?
|
Genes, Dominant | 1 | 2003 | 883 | 0.010 |
Why?
|
Lymphotoxin-alpha | 1 | 2000 | 96 | 0.010 |
Why?
|
Time Factors | 2 | 2012 | 40050 | 0.010 |
Why?
|
Likelihood Functions | 1 | 2003 | 1004 | 0.010 |
Why?
|
Adolescent | 9 | 2001 | 85405 | 0.010 |
Why?
|
Aged, 80 and over | 7 | 2001 | 57650 | 0.010 |
Why?
|
Heymann Nephritis Antigenic Complex | 1 | 1999 | 16 | 0.010 |
Why?
|
Liver Cirrhosis | 1 | 1989 | 1838 | 0.010 |
Why?
|
Logistic Models | 1 | 2014 | 13402 | 0.010 |
Why?
|
Eyelids | 1 | 2001 | 253 | 0.010 |
Why?
|
Hemorrhage | 1 | 2011 | 3441 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 2001 | 1421 | 0.010 |
Why?
|
Orbit | 1 | 2002 | 425 | 0.010 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2000 | 296 | 0.010 |
Why?
|
Histocompatibility Testing | 1 | 2000 | 741 | 0.010 |
Why?
|
Sex Ratio | 1 | 1998 | 110 | 0.010 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 1999 | 380 | 0.010 |
Why?
|
Sex Factors | 1 | 2012 | 10398 | 0.010 |
Why?
|
Fas Ligand Protein | 1 | 1999 | 217 | 0.010 |
Why?
|
Optic Nerve | 1 | 2001 | 558 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2001 | 1585 | 0.010 |
Why?
|
Thymus Hyperplasia | 1 | 1997 | 30 | 0.010 |
Why?
|
Penetrance | 1 | 1998 | 381 | 0.010 |
Why?
|
Cohort Studies | 2 | 2012 | 40389 | 0.010 |
Why?
|
Mutation | 1 | 2001 | 29658 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2007 | 21694 | 0.010 |
Why?
|
Antibody Formation | 1 | 2001 | 1398 | 0.010 |
Why?
|
Puerperal Disorders | 1 | 1999 | 279 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 1994 | 3863 | 0.010 |
Why?
|
Immunoradiometric Assay | 1 | 1995 | 24 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18349 | 0.010 |
Why?
|
Thymoma | 1 | 1997 | 186 | 0.010 |
Why?
|
Lymphocyte Activation | 2 | 1999 | 5522 | 0.010 |
Why?
|
Parathyroid Hormone | 1 | 2001 | 1799 | 0.010 |
Why?
|
Thymus Neoplasms | 1 | 1997 | 268 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2000 | 2881 | 0.010 |
Why?
|
Gene Frequency | 1 | 2001 | 3585 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 1998 | 1591 | 0.010 |
Why?
|
Family Health | 1 | 1998 | 1281 | 0.010 |
Why?
|
Visual Fields | 1 | 2000 | 1049 | 0.010 |
Why?
|
Administration, Oral | 1 | 2001 | 3909 | 0.010 |
Why?
|
False Negative Reactions | 1 | 1994 | 589 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2007 | 11347 | 0.010 |
Why?
|
Antigen Presentation | 1 | 1999 | 1286 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1994 | 1158 | 0.010 |
Why?
|
Child | 6 | 1999 | 77033 | 0.010 |
Why?
|
Genome | 1 | 2001 | 1794 | 0.010 |
Why?
|
Pregnancy Complications | 2 | 1999 | 2867 | 0.010 |
Why?
|
Family | 1 | 2003 | 3141 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14740 | 0.010 |
Why?
|
T-Lymphocytes | 2 | 2003 | 10142 | 0.010 |
Why?
|
Pedigree | 1 | 1998 | 4640 | 0.010 |
Why?
|
Prevalence | 1 | 2007 | 15153 | 0.010 |
Why?
|
Disabled Persons | 1 | 1999 | 1207 | 0.010 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 1989 | 65 | 0.010 |
Why?
|
Linear Models | 1 | 2000 | 5948 | 0.010 |
Why?
|
gamma-Glutamyltransferase | 1 | 1989 | 133 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2001 | 8605 | 0.010 |
Why?
|
Hepatic Encephalopathy | 1 | 1989 | 139 | 0.010 |
Why?
|
Lipids | 1 | 1999 | 3307 | 0.010 |
Why?
|
Bone Density | 1 | 2001 | 3471 | 0.010 |
Why?
|
Models, Genetic | 1 | 1998 | 3493 | 0.000 |
Why?
|
Aspartate Aminotransferases | 1 | 1989 | 418 | 0.000 |
Why?
|
False Positive Reactions | 1 | 1990 | 982 | 0.000 |
Why?
|
Recurrence | 1 | 1999 | 8307 | 0.000 |
Why?
|
Membrane Glycoproteins | 1 | 1999 | 3768 | 0.000 |
Why?
|
Radiotherapy Dosage | 1 | 1993 | 2872 | 0.000 |
Why?
|
Alanine Transaminase | 1 | 1989 | 591 | 0.000 |
Why?
|
Lymphatic Metastasis | 1 | 1994 | 2897 | 0.000 |
Why?
|
Alkaline Phosphatase | 1 | 1989 | 864 | 0.000 |
Why?
|
Computer Simulation | 1 | 1999 | 6237 | 0.000 |
Why?
|
Phenotype | 1 | 2003 | 16301 | 0.000 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1990 | 2558 | 0.000 |
Why?
|
Carrier Proteins | 1 | 1999 | 5012 | 0.000 |
Why?
|
Longevity | 1 | 1992 | 1066 | 0.000 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2003 | 15500 | 0.000 |
Why?
|
Hepatitis B | 1 | 1989 | 688 | 0.000 |
Why?
|
Chronic Disease | 1 | 1999 | 9133 | 0.000 |
Why?
|
Longitudinal Studies | 1 | 1999 | 13880 | 0.000 |
Why?
|
Carcinoma | 1 | 1995 | 2361 | 0.000 |
Why?
|
Apoptosis | 1 | 1999 | 9714 | 0.000 |
Why?
|
Bone Neoplasms | 1 | 1994 | 2521 | 0.000 |
Why?
|
Prospective Studies | 2 | 2001 | 53037 | 0.000 |
Why?
|
Membrane Proteins | 1 | 1999 | 7862 | 0.000 |
Why?
|
Flow Cytometry | 1 | 1992 | 5959 | 0.000 |
Why?
|
Health Status | 1 | 1995 | 4013 | 0.000 |
Why?
|
Adenoma | 1 | 1991 | 2167 | 0.000 |
Why?
|
Neoplasm Staging | 1 | 1994 | 10961 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 1997 | 15511 | 0.000 |
Why?
|
B-Lymphocytes | 1 | 1992 | 4663 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2000 | 20055 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1994 | 9122 | 0.000 |
Why?
|
Mice | 1 | 1999 | 81002 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 1994 | 12985 | 0.000 |
Why?
|